STTR Phase I: Oral Cancer Detection Using Redox Magnetohydrodynamic Microfluidics-based Bioassay Chips

Award Information
Agency:
National Science Foundation
Branch:
N/A
Amount:
$150,000.00
Award Year:
2007
Program:
STTR
Phase:
Phase I
Contract:
0712204
Agency Tracking Number:
0712204
Solicitation Year:
2006
Solicitation Topic Code:
BT
Solicitation Number:
NSF 06-598
Small Business Information
SFC Fluidics, LLC
535 W RESEARCH BLVD, SUITE 135,, 6745 HOLLISTER AVENUE, FAYETTEVILLE, AR, 72701
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
125518428
Principal Investigator
 Christine Evans
 Dr
 (479) 571-2592
 ceevans@sfc-fluidics.com
Business Contact
 Mark Wagstaff
Title: PhD
Phone: (479) 571-2592
Email: mwagstaff@virtual-incubation.com
Research Institution
 Univ of PA School of Medicine
 Barry L Ziober
 3451 Walnut St, P221 Franklin
Philadelphia, PA, 19104-6205
 (215) 898-7293
 Nonprofit college or university
Abstract
This Small Business Technology Transfer Research (STTR) Phase I project aims to develop a molecular signature-based redox magnetohydrodynamic (MHD) microfluidic system for the detection of oral cancer. The microfluidic chips are expected to interface with a handheld readout instrument that has a low operator skill requirement and is suited for point-of-care operation.If successful, the methodology can be used for early detection of oral squamous cell carcinoma, as well as other forms of cancer and as such may benefit a large number of individuals suffering from cancer.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government